No increased risk of glucose metabolism disorders in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope ®): data from an observational, longitudinal study

To evaluate the impact of treatment with recombinant human growth hormone (rhGH; Omnitrope ®) on the risk of diabetes mellitus in adults with growth hormone deficiency (GHD), using data from the ongoing PATRO A...

Source: BMC Endocrine Disorders - December 11, 2019 Category: Endocrinology Authors: Paolo Beck-Peccoz, Charlotte H öybye, Robert D. Murray, Suat Simsek, Markus Zabransky, Hichem Zouater and Günter Stalla Tags: Research article Source Type: research